“Same as Zepbound”
The FDA identifies sameness claims about compounded GLP-1 products as misleading.
Question brief
What does “compounded tirzepatide” mean?
It means a pharmacy or doctor made the medicine itself, rather than handing over the maker’s own approved Mounjaro or Zepbound. This part gets murky fast. Start here.
Product check
ApprovedCompounded
FDA reviewproduct-specific
Prescriptionneeded
Makername it
Compounded does not mean generic
A compounded medicine is made to order. It is not an FDA-approved generic, and the FDA does not check it for safety, effectiveness, or quality before marketing.
Compounding can meet a patient need that an approved product does not meet. That does not make every advertised copy lawful or appropriate.
Why the shortage keeps coming up
The national shortage once allowed copies under specific compounding rules. The FDA confirmed the tirzepatide shortage was over in December 2024.
Ordinary compounding pharmacies had until February 18, 2025 to stop making routine copies. Outsourcing facilities, the larger batch makers the FDA inspects, had until March 19, 2025. For a patient, a routine pharmacy copy is no longer allowed just because of the shortage. A pharmacy may make one only when the prescriber decides a change from the approved product matters for that patient specifically. As of September 2026, tirzepatide remained off the national shortage list.
Make the product traceable
- Which pharmacy made it?
- Is that pharmacy licensed to send medicine into my state?
- Why would I need a pharmacy-made version instead of Mounjaro or Zepbound? The FDA has said a copy being cheaper or easier to use is not a reason.
- What exact ingredient name appears on the label?
- Who answers a question about quality or a reaction?
Words that need a closer look
“FDA checked the pharmacy”
The FDA does not approve pharmacies or compounded medicines.
“Generic tirzepatide”
No approved tirzepatide generic existed as of September 2026.
Ready for the next piece?
Next: see the full cost picture